发明名称 CEFTOLOZANE PHARMACEUTICAL COMPOSITIONS
摘要 Pharmaceutical compositions can include an amount of sodium chloride effective to stabilize ceftolozane in an antibiotic formulation.
申请公布号 US2014275000(A1) 申请公布日期 2014.09.18
申请号 US201414212590 申请日期 2014.03.14
申请人 Cubist Pharmaceuticals, Inc. 发明人 Damour Nicole Miller;Terracciano Joseph
分类号 A61K31/546;A61K47/02 主分类号 A61K31/546
代理机构 代理人
主权项 1. A pharmaceutical composition comprising 125 mg to 500 mg sodium chloride per 1,000 mg of ceftolozane active, wherein the decrease in ceftolozane total purity is not greater than about 4% after storing the pharmaceutical composition for seven days in a sealed container at 60° C., as determined by HPLC using a Develosil column ODS-UG-5; 5 micrometers; 250×4.6 mm, a mobile phase of sodium perchlorate buffer solution (pH 2.5)/CH3CN 90:10 (v/v) at a 1.0 mL/min flow rate and oven temperature of 45° C.
地址 Lexington MA US